San Francisco squared off on April 25 against Walgreens Boots Alliance and three other companies accused of fueling an opioid crisis in the city, the first trial to target manufacturers, distributors and pharmacies over the addictive pain medicines.

Pfizer said on April 22 the company was voluntarily recalling five batches of Accupril blood pressure tablets after finding elevated levels of a potential cancer-causing agent in the medicine.

COVID-19 was the third leading cause of death in the United States for the second year in a row in 2021, with death rates rising for most age groups, a government study showed on April 22.

Health authorities around the world are investigating a mysterious increase in severe cases of hepatitis – inflammation of the liver – in young children.

Philadelphia is ending its indoor mask mandate, health officials said on April 21, reversing the city’s decision just days after imposing the order.

Amgen and AstraZeneca unveiled their first, direct-to-consumer U.S. advertising campaign in severe asthma called “Be You.” Launching ahead of Asthma & Allergy Awareness Month in May, the “Be You” campaign leverages visually distinct animated characters who do not let their disease define them. The campaign aims to raise awareness about a new severe asthma medicine called TEZSPIRE (tezepelumab-ekko).

Endo International plc announced that the Tennessee Court of Appeals reversed a trial court judge’s order denying a motion for recusal by Endo’s wholly owned subsidiaries Endo Health Solutions Inc. and Endo Pharmaceuticals Inc. in Clay County et al. v. Purdue Pharma, L.P., et al, pending in the Circuit Court for Cumberland County, Tennessee, and remanded the case for transfer to a different judge.

Fentanyl overdoses are now the top cause of death among U.S. residents ages 18-45, surpassing suicide, car accidents and COVID, according to an analysis of federal data by opioid awareness organization Families Against Fentanyl. To prevent such deaths, FentCheck’s co-founders and a team of volunteers regularly visit a network of businesses in Oakland, San Francisco, New York and Philadelphia to replenish stocks of the test strips.

A planned funding overhaul aimed at strengthening the World Health Organization (WHO) has been partly watered down, according to an internal document seen by Reuters, after pressure from the United States and other donor countries.

Alabama reached $276 million in settlements with Johnson & Johnson, McKesson Corp. and Endo International Plc, resolving claims that the companies fueled an opioid addiction crisis, the state attorney general said.